| abstract |
The present invention relates to a compound of formula (I): wherein R is -H or-F, P is -H or -a phosphoramidate, n is r 2, X is -NH2, -NHR or -OH, Y is -H or -NH2 and Z is -CH or -N, or a pharmacologically acceptable salt, or a pharmacologically acceptable salt, solvate, tautomeric and/or polymorphic form of the following compound (I), for use against alphavirus infections, in particular against CHIKV infections. |